Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice

Calcium-activated potassium channels – a therapeutic target for modulating nitric oxide in cardiovascular disease?

(2010) Thomas Dalsgaard et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Small conductance calcium-activated potassium channels: From structure to function

(2010) Kate L. Weatherall et al.   PROGRESS IN NEUROBIOLOGY

NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats

(2009) E Brøndum et al.   BRITISH JOURNAL OF PHARMACOLOGY

Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine β-Synthase–Deficient Mice

(2009) Daqing Zhang et al.   CIRCULATION

Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension

(2009) Sebastian Brähler et al.   CIRCULATION

Overexpression of Dimethylarginine Dimethylaminohydrolase Protects Against Cerebral Vascular Effects of Hyperhomocysteinemia

(2009) Roman N. Rodionov et al.   CIRCULATION RESEARCH

Losartan Prevents Portal Hypertension-Induced, Redox-Mediated Endothelial Dysfunction in the Mesenteric Artery in Rats

(2009) Stéphanie Dal–Ros et al.   GASTROENTEROLOGY

Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?

(2009) Federico Sesti et al.   TRENDS IN CELL BIOLOGY

Calcium-Activated Potassium Channels Contribute to Human Coronary Microvascular Dysfunction After Cardioplegic Arrest

(2008) J. Feng et al.   CIRCULATION

Cystathionine β-synthase p.S466L mutation causes hyperhomocysteinemia in mice

(2008) Sapna Gupta et al.   HUMAN MUTATION

Calcium-activated potassium channels contribute to human skeletal muscle microvascular endothelial dysfunction related to cardiopulmonary bypass

(2008) Yuhong Liu et al.   SURGERY